Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females
Open Access
- 6 November 2015
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 34 (1), 172-178
- https://doi.org/10.1016/j.vaccine.2015.09.087
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous ThromboembolismJAMA, 2014
- Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort studyBMJ, 2013
- Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to FemalesArchives of Pediatrics & Adolescent Medicine, 2012
- Trends in Venous Thromboembolism-Related Hospitalizations, 1994–2009Published by American Academy of Pediatrics (AAP) ,2012
- The Food and Drug Administration's Post‐Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprisePharmacoepidemiology and Drug Safety, 2012
- Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety DatalinkVaccine, 2011
- Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance OrganizationThe Pediatric Infectious Disease Journal, 2010
- Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink ProjectAmerican Journal of Epidemiology, 2009
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant VaccineJama-Journal Of The American Medical Association, 2009
- The worcester venous thromboembolism studyJournal of General Internal Medicine, 2006